Tolerability assessments
All subjects with drug-related AEs for the test and reference calcium dobesilate capsules under fasting conditions were reported by 0 and 1 (3.8%), respectively, while under fed conditions, drug-related AEs for test and reference were 4 (5.7%) and 9 (12.9%), respectively (